text stringlengths 0 197k |
|---|
Researchers will compare the metabolic profile of three groups: patients with chronic kidney disease, patients with metabolic syndrome and healthy subjects: |
* V'O2-adjusted lactate at rest and during exercise |
* The combination of exercise energy metabolism intermediates reflecting insulin resistance among Krebs cycle cofactors/substrates, ß-oxidation cofactors/substrates, amino acids conditions: Metabolic Syndrome conditions: Dialysis; Complications studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventio... |
<|newrecord|> nctId: NCT06360289 id: ALN-TTR-NT-003 briefTitle: Observational Study of Neurofilament Light Chain (NfL) as a Biomarker in Asymptomatic Carriers of the Transthyretin (TTR) Variants and Patients With Hereditary Transthyretin-mediated (hATTR) Amyloidosis With Polyneuropathy overallStatus: NOT_YET_RECRUITING... |
<|newrecord|> nctId: NCT06360276 id: 14012021 briefTitle: Effect of Seated Exercises and Psychoeducational Rehabilitation on Fatigue and Coping of Women Postmastectomy overallStatus: COMPLETED date: 2022-03-14 date: 2022-08-02 date: 2022-08-12 date: 2024-04-11 date: 2024-04-11 name: Alexandria University class: OTHER b... |
Hypotheses for research: |
1. Women with BC who receive seated exercises and psychoeducational rehabilitation using the teach-back approach after mastectomy exhibit less fatigue than those who do not. |
2. Women with BC who receive seated exercises and psychoeducational rehabilitation using the teach-back approach after mastectomy exhibit improved coping behaviors than those who do not. |
A quasi-experimental research was conducted in the main University Hospital, Alexandria, Egypt. A total of 60 women were randomly allocated to one of two groups.; women in the study group practiced seated exercises and psychological rehabilitation interventions, including mindfulness breathing, problem-solving training... |
<|newrecord|> nctId: NCT06360263 id: #1-6/2023 briefTitle: OSSEODENSIFICATION BY DENSAH BURS WITH ACTIVATED PLASMA ALBUMIN GEL FOR SINUS LIFTING WITH SIMULTANEOUS IMPLANT PLACEMENT overallStatus: RECRUITING date: 2023-07-11 date: 2024-08 date: 2024-08 date: 2024-04-11 date: 2024-04-11 name: Esraa Salem Kamal class: OTH... |
<|newrecord|> nctId: NCT06360250 id: B2001-F20220601 briefTitle: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation overallStatus: NOT_YET_RECRUITING date: 2024-04-10 date: 2024-10-30 date: 20... |
<|newrecord|> nctId: NCT06360237 id: ISIS 678354 briefTitle: Olezarsen Early Access Program for Patients With Familial Chylomicronemia Syndrome (FCS) overallStatus: AVAILABLE date: 2024-04-11 date: 2024-04-11 name: Ionis Pharmaceuticals, Inc. class: INDUSTRY briefSummary: The purpose of the Expanded Access Program is t... |
<|newrecord|> nctId: NCT06360224 id: CASES briefTitle: Collect Flow and Ultrasound Images of Coronary Bypass Grafts acronym: CASES overallStatus: NOT_YET_RECRUITING date: 2024-05-15 date: 2029-05-15 date: 2029-05-15 date: 2024-04-11 date: 2024-04-11 name: Medistim ASA class: INDUSTRY briefSummary: This is a post-market... |
<|newrecord|> nctId: NCT06360211 id: 22251 briefTitle: A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants overallStatus: RECRUITING date: 2024-04-17 date: 2024-06-11 date: 2024-06-11 date: 2024-04-11 date: 2024-04-22 name: Bayer c... |
Advanced NSCLC refers to a type of lung cancer that has spread from the lungs to nearby tissues or other body parts. People with advanced NSCLC may have changes in certain proteins like EGFR and HER2 that cause uncontrolled cell growth and increased spread of cancer. |
In this study, participants will be healthy and will not benefit from taking the study treatment, BAY2927088. However, the study will provide information about how to test BAY2927088 in future studies on people with advanced NSCLC with EGFR or HER2 mutations. |
BAY2927088 is under development for the treatment of advanced NSCLC with EGFR or HER2 mutations. It is expected to work against these changed proteins, which might slow down the spread of cancer. |
Researchers think that BAY2927088 might affect an enzyme (called CYP3A4) that breaks down drugs in the body. This might make the effects of some drugs weaker or stronger. Midazolam is a drug that is broken down by CYP3A4. By studying the level of midazolam in the blood, researchers can understand how BAY2927088 might i... |
The main purpose of this study is to find out how BAY2927088, taken as a single dose and as multiple doses, affects the level of another drug, called midazolam, in the blood of healthy participants. To achieve this goal, researchers will measure the following for midazolam when participants take it with or without BAY2... |
* Area under the curve (AUC): a measure of the total amount of midazolam in participants' blood over time |
* Maximum observed concentration (Cmax): the highest amount of midazolam in participants' blood |
The study will have 3 treatment periods: |
Period 1 (Day 1 to Day 2): On Day 1, participants will take midazolam Period 2 (Day 3 to Day 4): On Day 3, participants will take midazolam with BAY2927088 Period 3 (Day 5 to Day 15): On Days 5 to 13, participants will take BAY2927088 On Day 14, participants will take midazolam with BAY2927088 |
Participants will be part of the study for about 8 weeks with at least 3 visits to the study clinic. |
Participants will visit the study clinic: |
* More than/at least once, within 2 to 28 days before the treatment starts |
* Once on the day before the treatment starts and will stay in the clinic until Day 15 of the treatment |
* Once, within 7 to 10 days after they finish treatment for a health checkup |
During the study, the doctors and their study team will: |
* do physical examinations |
* collect blood samples from the participants to measure the blood levels of midazolam and of BAY2927088 |
* check participants' health by performing tests such as blood and urine tests, and checking heart health using an electrocardiogram (ECG) |
* ask the participants questions about how they are feeling and what adverse events they are having |
An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment. conditions: Advanced Non-small Cell Lung Cancer conditions: EGFR Mutation conditions: HER2 Mutation conditions: Healthy Volunte... |
<|newrecord|> nctId: NCT06360198 id: 2022-874/08 briefTitle: The Relationship Between Posture, Sense of Position, Musculoskeletal Discomfort and Anxiety overallStatus: COMPLETED date: 2022-06-30 date: 2022-11-30 date: 2022-12-30 date: 2024-04-11 date: 2024-04-11 name: Ankara Yildirim Beyazıt University class: OTHER bri... |
<|newrecord|> nctId: NCT06360185 id: Asthma V2 October 2023 briefTitle: Retrospective Study of Patients With Acute Presentation for Asthma to an Emergency Department in UK (RAPAE) acronym: RAPAE overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-12-01 date: 2025-12-01 date: 2024-04-11 date: 2024-04-11 name: ... |
<|newrecord|> nctId: NCT06360172 id: 3-2024 briefTitle: The Feasibility of Motivational Interviewing on Emotional Authenticity, Dispositional Optimism, And Academic Motivation Among Nursing Students: A Randomized Controlled Trial overallStatus: ACTIVE_NOT_RECRUITING date: 2024-03-20 date: 2024-06-01 date: 2024-06-15 da... |
<|newrecord|> nctId: NCT06360159 id: Massage on Newborns briefTitle: Massage for Newborns Receiving Nasal CPAP overallStatus: NOT_YET_RECRUITING date: 2024-05-15 date: 2026-05-15 date: 2026-05-15 date: 2024-04-11 date: 2024-04-15 name: Sultan Besiktas class: OTHER briefSummary: One of the most frequently required treat... |
Gastric-abdominal distension, which is a complication of NCPAP application, is caused by gas entering the stomach and gastrointestinal tract. Feeding intolerance may develop in the newborn due to abdominal distension. In recent studies, it has been determined that non-pharmacological methods and supportive developmenta... |
Control group: Apart from clinical routine practices, salivary cortisol samples will be taken from newborn babies in the control group and abdominal circumference of the babies will be measured. primaryPurpose: SUPPORTIVE_CARE masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 36 type: ESTIMATED... |
<|newrecord|> nctId: NCT06360146 id: 120685123 briefTitle: Early Mobilisation of Post Cardiac Surgery in Geriatrics. overallStatus: ENROLLING_BY_INVITATION date: 2023-04-01 date: 2023-06-01 date: 2024-06-01 date: 2024-04-11 date: 2024-04-11 name: Ahi Evran University Education and Research Hospital class: OTHER briefSu... |
Following heart surgery, patients who are active in the postoperative phase stay in the hospital for shorter periods of time and experience fewer complications. |
After cardiac surgery, older adults who exercise during the recovery period experience fewer difficulties and hospitalizations. |
A total of 100 elderly patients-69 men and 31 women-who had undergone cardiac surgery and were up to 65 years old-voluntarily took part in the study. There were fifty patients in each of the two groups that the participants were divided into: the early mobilization group (Group A) and the control group (Group B). |
Older patients undergoing cardiac surgery also experienced improved balance as a result of early mobilization and functional exercises. conditions: Cardiac Disease studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized controlled trial primaryPur... |
<|newrecord|> nctId: NCT06360133 id: VVN001-CCS-301 briefTitle: Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2026-03 date: 2026-03 date: 2024-04-11 date: 2024-04-11 name: VivaVision Biotech, Inc class: INDUSTRY briefSummary: This is a Phase 3, randomize... |
<|newrecord|> nctId: NCT06360120 id: 00023098816 briefTitle: Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke overallStatus: RECRUITING date: 2024-04-10 date: 2025-04-10 date: 2025-05-10 date: 2024-04-11 date: 2024-04-11 name: Kafrelsheikh University class: OT... |
<|newrecord|> nctId: NCT06360107 id: 76729 briefTitle: RCT of a Brief Video Intervention Targeting Peer Inclusion to Reduce Depression-related Stigma in Adolescents overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-07 date: 2024-07 date: 2024-04-11 date: 2024-04-11 name: New York State Psychiatric Institute cl... |
Timely identification and treatment of depression in adolescents is a public health priority. However, most youth with depression do not seek treatment, and stigma has been identified as the primary barrier to help-seeking. Experiments have found brief video-based interventions (BVIs), 1-2 minute videos similar to thos... |
In this 3-arm RCT, we will recruit adolescents aged 14-18 using an online crowdsourcing platform, to test the efficacy of a) standard BVI that addresses mental health treatment but does not address concerns about peer inclusion/exclusion, b) novel BVI focused on mental health treatment and peer inclusion, and c) contro... |
<|newrecord|> nctId: NCT06360094 id: 1490-0004 id: 2023-510249-79-00 type: REGISTRY domain: CTIS id: U1111-1301-1311 type: REGISTRY domain: WHO Registry (ICTRP) briefTitle: A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis overallStatus: NOT... |
Participants who have IPF are put into 4 groups by chance. Participants in 3 groups get different doses of BI 1839100. Participants in 1 group get placebo. Placebo looks like BI 1839100 but does not contain any medicine. Participants take the treatment for 3 months. After 1 month of treatment, participants who take the... |
During the study, coughing is measured over 24 hours about once per month using a portable device given to participants to use during the study. Participants fill in questionnaires about their coughing. Doctors also perform breathing tests that measure how well the lungs are working at the site visits. Researchers comp... |
<|newrecord|> nctId: NCT06360081 id: 1479-0019 id: 2023-510495-31-00 type: OTHER domain: CTIS id: U1111-1303-4345 type: OTHER domain: WHO briefTitle: A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers overallStatus: NOT_YET_RECRUITING da... |
<|newrecord|> nctId: NCT06360068 id: SLE-SASP POC id: 82371767 type: OTHER_GRANT domain: National Natural Science Foundation of China briefTitle: A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus overallStatus: NOT_YET_RECRUIT... |
Does drug sulfasalazine with stable background treatment help lower the disease activity (SLEDAI) at week 16? How many patients can reach SRI-4 at week 16? Can this regimen help lower the prednisone dosage the patients need at week 16? What about the change of the type I interferon related genes expression at week 16? |
Participants will: |
Take sulfasalazine 750mg/dose, twice a day for 16 weeks. The dosage will be increased to 1000mg/dose within one month, twice a day if the patient could tolerate. |
Visit the clinic once every 4 weeks for checkups and tests. conditions: Systemic Lupus Erythematosus studyType: INTERVENTIONAL phases: PHASE2 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 20 type: ESTIMATED name: Sulfasalazine Tablets measure: the change of disease activi... |
<|newrecord|> nctId: NCT06360055 id: M2024130 briefTitle: Effect of Oral D-mannose Tablets on Pharmacokinetics of Dabigatranate in Healthy Adults overallStatus: RECRUITING date: 2024-04-01 date: 2024-11-30 date: 2024-12-31 date: 2024-04-11 date: 2024-04-11 name: Peking University Third Hospital class: OTHER briefSummar... |
<|newrecord|> nctId: NCT06360042 id: MA-HCC-II-021 briefTitle: Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC overallStatus: RECRUITING date: 2024-01-01 date: 2027-03-31 date: 2028-03-31 date: 2024-04-11 date: 2024-04-22 name: Peking University Cancer Hospital & Instit... |
<|newrecord|> nctId: NCT06360029 id: LvL UP briefTitle: The LvL UP Pilot Trial overallStatus: RECRUITING date: 2024-04-15 date: 2024-06 date: 2024-06 date: 2024-04-11 date: 2024-04-17 name: Singapore ETH Centre class: OTHER name: ETH Zurich name: National University of Singapore name: Nanyang Technological University b... |
LvL UP is a mHealth intervention aimed at preventing NCDs and CMDs in adults from multi-ethnic Southeast Asian populations (Castro et al., 2023). Building upon leading evidence- and theory-based frameworks in the areas of mental health and behaviour change, a multidisciplinary team of researchers developed LvL UP as a ... |
The goal of this pilot study is to assess the feasibility of a Sequential, Multiple Assignment, Randomized Trial (SMART) aimed at (i) evaluating the effectiveness and cost-effectiveness of LvL UP and (ii) establishing the optimal blended approach in LvL UP that balances effective personalized lifestyle support with sca... |
1. What are the intervention's preliminary, short-term effects? What is the intervention's level of engagement? What is the number of dropouts? What is the percentage of missing data? What is the intervention's responder / non-responder rate after week 4? How easy was to recruit the target sample size and which channel... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.